• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔一氧化氮可能无法区分原发性纤毛运动障碍与某些原发性免疫缺陷。

Nasal nitric oxide May not differentiate primary ciliary dyskinesia from certain primary immunodeficiencies.

机构信息

Division of Pediatric Pulmonary, Allergy and Sleep Medicine, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Division of Pediatric Pulmonology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

出版信息

Pediatr Pulmonol. 2022 Sep;57(9):2269-2272. doi: 10.1002/ppul.25989. Epub 2022 Jun 2.

DOI:10.1002/ppul.25989
PMID:35596239
Abstract

The diagnosis of primary ciliary dyskinesia (PCD) is made through a combination of clinical features supported by a panel of diagnostic tests. Our cases highlight the similarities in the clinical presentation of patients with the specific immunodeficiency activated phosphatidylinositol 3-kinase delta syndrome 1 (or PIK3CD-related disorder) and PCD. We highlight the importance of repeating nasal nitric oxide testing when PCD has not been confirmed by genetic or ciliary electron micrograph analysis in the setting of an expanded suppurative lung disease differential that includes considerations for immunodeficiency as well as PCD.

摘要

原发性纤毛运动障碍(PCD)的诊断是通过临床特征与一系列诊断测试相结合得出的。我们的病例突出了具有特定免疫缺陷激活的磷脂酰肌醇 3-激酶 δ 综合征 1(或 PIK3CD 相关疾病)和 PCD 患者的临床表现的相似性。我们强调了在扩展的化脓性肺病鉴别诊断中,当遗传或纤毛电子显微镜分析未证实 PCD 时,重复鼻一氧化氮测试的重要性,该鉴别诊断包括对免疫缺陷以及 PCD 的考虑。

相似文献

1
Nasal nitric oxide May not differentiate primary ciliary dyskinesia from certain primary immunodeficiencies.鼻腔一氧化氮可能无法区分原发性纤毛运动障碍与某些原发性免疫缺陷。
Pediatr Pulmonol. 2022 Sep;57(9):2269-2272. doi: 10.1002/ppul.25989. Epub 2022 Jun 2.
2
Progress in diagnosis of primary ciliary dyskinesia.原发性纤毛运动障碍的诊断进展。
J Paediatr Child Health. 2022 Oct;58(10):1736-1740. doi: 10.1111/jpc.16196. Epub 2022 Sep 7.
3
Implementation of a screening tool for primary ciliary dyskinesia (PCD) in a pediatric otolaryngology clinic.在儿科耳鼻喉科诊所实施原发性纤毛运动障碍(PCD)筛查工具。
Int J Pediatr Otorhinolaryngol. 2021 Mar;142:110586. doi: 10.1016/j.ijporl.2020.110586. Epub 2020 Dec 31.
4
Use caution interpreting nasal nitric oxide: Overlap in primary ciliary dyskinesia and primary immunodeficiency.解读鼻一氧化氮时需谨慎:原发性纤毛运动障碍与原发性免疫缺陷存在重叠。
Pediatr Pulmonol. 2021 Dec;56(12):4045-4047. doi: 10.1002/ppul.25636. Epub 2021 Sep 2.
5
Nasal Nitric Oxide in Primary Immunodeficiency and Primary Ciliary Dyskinesia: Helping to Distinguish Between Clinically Similar Diseases.原发性免疫缺陷病和原发性纤毛运动障碍中鼻内一氧化氮:有助于鉴别临床相似疾病。
J Clin Immunol. 2019 Feb;39(2):216-224. doi: 10.1007/s10875-019-00613-8. Epub 2019 Mar 26.
6
Nasal Nitric Oxide Measurement and a Modified PICADAR Score for the Screening of Primary Ciliary Dyskinesia in Adults with Bronchiectasis.鼻腔一氧化氮测量及改良PICADAR评分在成人支气管扩张症患者原发性纤毛运动障碍筛查中的应用
Pneumologie. 2017 Aug;71(8):543-548. doi: 10.1055/s-0043-111909. Epub 2017 Aug 7.
7
Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure.正常超微结构原发性纤毛运动障碍的鼻一氧化氮测量诊断的局限性。
Ann Am Thorac Soc. 2022 Aug;19(8):1275-1284. doi: 10.1513/AnnalsATS.202106-728OC.
8
Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols.原发性纤毛运动障碍的鼻一氧化氮测量。标准化测试方案技术论文。
Ann Am Thorac Soc. 2020 Feb;17(2):e1-e12. doi: 10.1513/AnnalsATS.201904-347OT.
9
Accuracy of Nasal Nitric Oxide Measurement as a Diagnostic Test for Primary Ciliary Dyskinesia. A Systematic Review and Meta-analysis.鼻一氧化氮测量作为原发性纤毛运动障碍诊断试验的准确性:一项系统评价和荟萃分析
Ann Am Thorac Soc. 2017 Jul;14(7):1184-1196. doi: 10.1513/AnnalsATS.201701-062SR.
10
Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children.原发性纤毛运动障碍、囊性纤维化及健康儿童的鼻腔一氧化氮水平
Turk J Pediatr. 2019;61(1):20-25. doi: 10.24953/turkjped.2019.01.004.

引用本文的文献

1
Primary ciliary dyskinesia.原发性纤毛运动障碍
Paediatr Child Health. 2025 Apr 3;30(4):203-211. doi: 10.1093/pch/pxae102. eCollection 2025 Jul.
2
Feasibility of Machine Learning Analysis for the Identification of Patients with Possible Primary Ciliary Dyskinesia.机器学习分析用于识别可能患有原发性纤毛运动障碍患者的可行性
medRxiv. 2025 Apr 20:2025.04.18.25326065. doi: 10.1101/2025.04.18.25326065.
3
Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS).活化磷脂酰肌醇3-激酶δ综合征(APDS)患者的总生存期。
Orphanet J Rare Dis. 2025 May 3;20(1):212. doi: 10.1186/s13023-025-03734-z.
4
Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.原发性纤毛运动障碍或活化磷脂酰肌醇3-激酶δ综合征患者的重叠临床表型
J Pediatr. 2025 May;280:114499. doi: 10.1016/j.jpeds.2025.114499. Epub 2025 Feb 6.
5
Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review.活化磷脂酰肌醇3-激酶δ综合征的遗传病因与恶性肿瘤及死亡率的结局:一项系统综述
Adv Ther. 2025 Feb;42(2):752-771. doi: 10.1007/s12325-024-03066-7. Epub 2024 Dec 5.
6
Primary Ciliary Dyskinesia.原发性纤毛运动障碍。
Pediatrics. 2024 Jun 1;153(6). doi: 10.1542/peds.2023-063064.
7
The utility of nasal nitric oxide in the diagnostic evaluation of primary ciliary dyskinesia.鼻腔一氧化氮在原发性纤毛运动障碍诊断评估中的应用。
Pediatr Pulmonol. 2024 May;59(5):1410-1417. doi: 10.1002/ppul.26929. Epub 2024 Feb 21.